Literature DB >> 15250587

Role of the GABA transporter in epilepsy.

George B Richerson1, Yuanming Wu.   

Abstract

The GABA transporter plays a well-established role in reuptake of GABA after synaptic release. The anticonvulsant effect of tiagabine appears to result largely from blocking this reuptake. However, there is another side to the GABA transporter, contributing to GABA release by reversing in response to depolarization. We have recently shown that this form of GABA release is induced by even small increases in extracellular [K+], and has a powerful inhibitory effect on surrounding neurons. This transporter-mediated GABA release is enhanced by the anticonvulsants gabapentin and vigabatrin. The latter drug also potently increases ambient [GABA], inducing tonic inhibition of neurons. Here we review the evidence in support of a physiological role for GABA transporter reversal, and the evidence that it is increased by high-frequency firing. We postulate that the GABA transporter is a major determinant of the level of tonic inhibition, and an important source of GABA release during seizures. These recent findings indicate that the GABA transporter plays a much more dynamic role in control of brain excitability than has previously been recognized. Further defining this role may lead to a better understanding of the mechanisms of epilepsy and new avenues for treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15250587     DOI: 10.1007/978-1-4757-6376-8_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  24 in total

1.  Energy landscape of LeuT from molecular simulations.

Authors:  Mert Gur; Elia Zomot; Mary Hongying Cheng; Ivet Bahar
Journal:  J Chem Phys       Date:  2015-12-28       Impact factor: 3.488

2.  Functional and structural determinants of reverse operation in the pH-dependent oligopeptide transporter PepT1.

Authors:  Maria Daniela Renna; Ayodele Stephen Oyadeyi; Elena Bossi; Gabor Kottra; Antonio Peres
Journal:  Cell Mol Life Sci       Date:  2010-12-23       Impact factor: 9.261

3.  A thalamic sleep tonic.

Authors:  Kevin J Staley; John R Huguenard
Journal:  Epilepsy Curr       Date:  2006 Sep-Oct       Impact factor: 7.500

Review 4.  Crystal structures of all-alpha type membrane proteins.

Authors:  Karen McLuskey; Aleksander W Roszak; Yanshi Zhu; Neil W Isaacs
Journal:  Eur Biophys J       Date:  2009-10-14       Impact factor: 1.733

5.  Substrate binds in the S1 site of the F253A mutant of LeuT, a neurotransmitter sodium symporter homologue.

Authors:  Hui Wang; Eric Gouaux
Journal:  EMBO Rep       Date:  2012-07-27       Impact factor: 8.807

6.  Structures of LeuT in bicelles define conformation and substrate binding in a membrane-like context.

Authors:  Hui Wang; Johannes Elferich; Eric Gouaux
Journal:  Nat Struct Mol Biol       Date:  2012-01-15       Impact factor: 15.369

Review 7.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

8.  GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum.

Authors:  Chi-Sung Chiu; Stephen Brickley; Kimmo Jensen; Amber Southwell; Sheri Mckinney; Stuart Cull-Candy; Istvan Mody; Henry A Lester
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

9.  A competitive inhibitor traps LeuT in an open-to-out conformation.

Authors:  Satinder K Singh; Chayne L Piscitelli; Atsuko Yamashita; Eric Gouaux
Journal:  Science       Date:  2008-12-12       Impact factor: 47.728

10.  GATMD: γ-aminobutyric acid transporter mutagenesis database.

Authors:  Cynthia M Anderson; Patrick D Kidd; Sepehr Eskandari
Journal:  Database (Oxford)       Date:  2010-12-02       Impact factor: 3.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.